223 related articles for article (PubMed ID: 17220280)
1. Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor.
Ying H; Araki O; Furuya F; Kato Y; Cheng SY
Mol Cell Biol; 2007 Mar; 27(6):2359-71. PubMed ID: 17220280
[TBL] [Abstract][Full Text] [Related]
2. Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms.
Mishra A; Zhu XG; Ge K; Cheng SY
J Mol Endocrinol; 2010 Apr; 44(4):247-55. PubMed ID: 20080985
[TBL] [Abstract][Full Text] [Related]
3. NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis.
Zhu XG; Kim DW; Goodson ML; Privalsky ML; Cheng SY
J Mol Endocrinol; 2011 Jun; 46(3):233-44. PubMed ID: 21389087
[TBL] [Abstract][Full Text] [Related]
4. A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.
Kim DW; Park JW; Willingham MC; Cheng SY
Hum Mol Genet; 2014 May; 23(10):2651-64. PubMed ID: 24381310
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α.
Fozzatti L; Kim DW; Park JW; Willingham MC; Hollenberg AN; Cheng SY
Proc Natl Acad Sci U S A; 2013 May; 110(19):7850-5. PubMed ID: 23610395
[TBL] [Abstract][Full Text] [Related]
7. Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms.
Araki O; Ying H; Zhu XG; Willingham MC; Cheng SY
Mol Endocrinol; 2009 Mar; 23(3):308-15. PubMed ID: 19131509
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Araki O; Ying H; Furuya F; Zhu X; Cheng SY
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
[TBL] [Abstract][Full Text] [Related]
9. NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1.
Han CR; Park S; Cheng SY
Sci Rep; 2017 Dec; 7(1):18080. PubMed ID: 29273766
[TBL] [Abstract][Full Text] [Related]
10. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice.
Cheng SY
Steroids; 2005; 70(5-7):450-4. PubMed ID: 15862829
[TBL] [Abstract][Full Text] [Related]
11. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice.
Kaneshige M; Suzuki H; Kaneshige K; Cheng J; Wimbrow H; Barlow C; Willingham MC; Cheng S
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15095-100. PubMed ID: 11734632
[TBL] [Abstract][Full Text] [Related]
12. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
[TBL] [Abstract][Full Text] [Related]
13. Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)α1 and TRα2: clinical, biochemical, and genetic analyses of three related patients.
Moran C; Agostini M; Visser WE; Schoenmakers E; Schoenmakers N; Offiah AC; Poole K; Rajanayagam O; Lyons G; Halsall D; Gurnell M; Chrysis D; Efthymiadou A; Buchanan C; Aylwin S; Chatterjee KK
Lancet Diabetes Endocrinol; 2014 Aug; 2(8):619-26. PubMed ID: 24969835
[TBL] [Abstract][Full Text] [Related]
14. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
[TBL] [Abstract][Full Text] [Related]
15. Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes.
Yuyama M; Fujimori K
Biochem J; 2014 May; 459(3):489-503. PubMed ID: 24511897
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activated receptor-gamma (PPARgamma) represses thyroid hormone signaling in growth plate chondrocytes.
Wang L; Shao YY; Ballock RT
Bone; 2005 Sep; 37(3):305-12. PubMed ID: 16023420
[TBL] [Abstract][Full Text] [Related]
17. Constitutive coactivator of peroxisome proliferator-activated receptor (PPARgamma), a novel coactivator of PPARgamma that promotes adipogenesis.
Li D; Kang Q; Wang DM
Mol Endocrinol; 2007 Oct; 21(10):2320-33. PubMed ID: 17595322
[TBL] [Abstract][Full Text] [Related]
18. The DLK gene is a transcriptional target of PPARγ.
Couture JP; Blouin R
Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338
[TBL] [Abstract][Full Text] [Related]
19. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
20. Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors.
Fozzatti L; Lu C; Kim DW; Cheng SY
Mol Endocrinol; 2011 Jun; 25(6):908-21. PubMed ID: 21474540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
